Translational and experimental ophthalmology bridges the gap between laboratory research and clinical practice, turning scientific discoveries into practical treatments. By focusing on innovative research, this field seeks to translate basic science into real-world applications, offering new treatments for ocular diseases such as retinal degeneration, corneal disorders, and optic neuropathies. Advances in gene therapy, stem cell research, and novel drug delivery systems are among the key areas driving progress. This research is crucial for improving treatments for conditions like age-related macular degeneration, where conventional therapies often fall short. Translational efforts are not only focused on developing new therapies but also on optimizing current treatment protocols to improve patient outcomes. The ultimate goal is to improve patient care by integrating cutting-edge scientific findings into clinical practice, offering hope for individuals with conditions that were once considered untreatable.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Diagnostic uncertainty with a patient presenting with raised intra-ocular pressure. A unique case of choroidal melanoma
Raheel Faiz, UHCW, United Kingdom
Title : Subthreshold micropulse laser for residual subretinal fluid after vitrectomy in myopic tractional maculopathy?A randomized controlled trial
Zhang Xifang, Beijing Tongren Hospital, China
Title : Hitting the trifecta-ocular syphilis
Lisa Sunny, Aravind Eye Hospital, India
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and vision Disorders, Poland